Literature DB >> 27443515

High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.

Hadi Shojaei1, Hong Hong1, Raymond W Redline2.   

Abstract

Yolk sac tumors occur at both gonadal and extra-gonadal sites. A recent case of ovarian endometrioid-pattern yolk sac tumor with strong diffuse expression of TTF-1 illustrated the potential for misdiagnosis due to divergent expression of endodermal lineage markers. The aim of this study was to investigate the expression of four divergent endodermal lineage markers, TTF-1, CDX2, Hep Par 1, and Napsin A, in gonadal and extra-gonadal yolk sac tumors of differing age, sex, and location (excluding foci of overt hepatoid differentiation). We identified 26 cases (5 ovarian, 15 testicular, and 6 extra-gonadal) containing yolk sac tumor as identified by typical histology and confirmed by positive immunohistochemical staining for alpha-fetoprotein and glypican-3. Mixed or ambiguous foci were confirmed by immunohistochemistry (SALL4 positive and Oct-4 negative). The relative proportion of three histologic patterns: reticular/cystic, solid/myxoid, and glandular was estimated. Percent positivity for the four divergent endodermal lineage markers was compared within yolk sac tumor areas according to site, age group, and histologic pattern. High-level (>25%) staining for one or more divergent endodermal lineage markers was seen in eleven cases: Hep Par 1 in seven cases, all post-pubertal, TTF-1 in four cases, two ovarian and two extra-gonadal, and CDX2 in three cases, with no age or site predilection. No case highly expressed all three divergent endodermal lineage markers, but four co-expressed high levels of two markers: two ovarian yolk sac tumors with TTF-1 and Hep Par 1, one testicular yolk sac tumor with CDX2 and Hep Par 1, and one extra-gonadal yolk sac tumors with TTF-1 and CDX2. While no absolute correlation of high-level divergent endodermal lineage marker expression with histologic subtype was observed, TTF-1 and CDX2 expression was predominantly seen in reticular/cystic and glandular areas while Hep Par 1 was most frequent in myxoid/solid and glandular areas.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27443515     DOI: 10.1038/modpathol.2016.131

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  60 in total

1.  Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament

Authors: 
Journal:  Arch Pathol Lab Med       Date:  2000-03       Impact factor: 5.534

2.  Placental yolk sac tumor with divergent endodermal differentiation.

Authors:  Taka-Aki Matsuyama; Miki Kushima; Toshiko Yamochi-Onizuka; Hidekazu Ota
Journal:  Int J Gynecol Pathol       Date:  2004-10       Impact factor: 2.762

3.  Differentiation of the embryonic disc, amnion, and yolk sac in the rhesus monkey.

Authors:  A C Enders; S Schlafke; A G Hendrickx
Journal:  Am J Anat       Date:  1986-10

4.  Formation and differentiation of extraembryonic mesoderm in the rhesus monkey.

Authors:  A C Enders; B F King
Journal:  Am J Anat       Date:  1988-04

5.  Yolk sac tumor of the bladder.

Authors:  G Taylor; M Jordan; B Churchill; K Mancer
Journal:  J Urol       Date:  1983-03       Impact factor: 7.450

6.  Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases.

Authors:  F F Nogales; C Bergeron; R E Carvia; T Alvaro; H R Fulwood
Journal:  Am J Surg Pathol       Date:  1996-09       Impact factor: 6.394

7.  Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

Authors:  Russell Vang; Allen M Gown; Lee-Shu-Fune Wu; Todd S Barry; Darren T Wheeler; Anna Yemelyanova; Jeffrey D Seidman; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2006-09-15       Impact factor: 7.842

8.  Cdx1 and cdx2 expression during intestinal development.

Authors:  D G Silberg; G P Swain; E R Suh; P G Traber
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

9.  Thyroid transcription factor-1 expression in breast carcinomas.

Authors:  Judith Robens; Lynn Goldstein; Allen M Gown; Stuart J Schnitt
Journal:  Am J Surg Pathol       Date:  2010-12       Impact factor: 6.394

10.  Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype.

Authors:  Jolanta Słowikowska-Hilczer; Tomasz E Romer; Krzysztof Kula
Journal:  J Androl       Date:  2003 Mar-Apr
View more
  5 in total

1.  Primary yolk sac tumour of the prostate mimicking small round blue cell tumour.

Authors:  H Gui; R A Kolster; M B Palmer; J S Brooks; M Zhang; M A Husson
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

2.  [Diagnosis and treatment of seven primary mediastinal yolk sac tumors].

Authors:  Y X Ma; J W Liu; K Qi; J X Zhang; G Lin; H B Liu; X Q Shang; J Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

Review 3.  [Current view on testicular tumors from a developmental biological perspective : Important biomarkers and molecular pathological investigations].

Authors:  Alexa Stephan; Mara Kotthoff; Felix Bremmer; Daniel Nettersheim
Journal:  Pathologie (Heidelb)       Date:  2022-08-01

Review 4.  American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.

Authors:  Andrew M Bellizzi; Elizabeth A Montgomery; Jason L Hornick
Journal:  Ann Diagn Pathol       Date:  2019-11-15       Impact factor: 2.090

5.  High-dose chemotherapy and stem-cell rescue for salvage therapy for relapsed malignant mixed ovarian germ cell tumor: A case report.

Authors:  Sarah Sears; Sareena Singh; Hadi Shojaei; Raymond Redline; Kimberly Resnick
Journal:  Gynecol Oncol Rep       Date:  2017-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.